Search results for "hazard"

showing 10 items of 1517 documents

Serum uric acid as an independent predictor of mortality in patients with angiographically proven coronary artery disease.

2002

It is a matter of controversy as to whether uric acid is an independent predictor of mortality in patients with coronary artery disease (CAD) or whether it represents only an indirect marker of adverse outcome by reflecting the association between uric acid and other cardiovascular risk factors. Therefore, we studied the influence of uric acid levels on mortality in patients with CAD. In 1,017 patients with angiographically proven CAD, classic risk factors and uric acid levels were determined at enrollment. A follow-up over a median of 2.2 years (maximum 3.1) was performed. Death from all causes was defined as an end point of the study. In CAD patients with uric acid levels303 micromol/L (5…

AdultMalemedicine.medical_specialtyCoronary Artery DiseaseCoronary AngiographyCoronary artery diseasechemistry.chemical_compoundPredictive Value of TestsRisk FactorsInternal medicineGermanymedicineHumansSurvival analysisAgedProportional Hazards ModelsProportional hazards modelbusiness.industryMortality rateHazard ratioMiddle Agedmedicine.diseaseSurvival AnalysisConfidence intervalUric AcidQuartilechemistryCardiologyUric acidFemaleCardiology and Cardiovascular MedicinebusinessBiomarkersThe American journal of cardiology
researchProduct

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autogra…

2011

Contains fulltext : 95663.pdf (Publisher’s version ) (Closed access) We present results of a phase 3 randomized trial of autografting in chronic lymphocytic leukemia versus observation for responding patients after first- or second-line treatment. The primary objective was to demonstrate that autografting improves the 5-year event-free survival (EFS) from 30% to 50%. There were 223 enrolled patients, 72% men and 28% women, 83% after first and 17% after second-line treatment. Binet stages were progressive A 13%, B 67%, C 20%; at randomization, 59% were in complete remission, and 41% in less than complete remission. Patients were randomized between autografting (n = 112) and observation (n = …

AdultMalemedicine.medical_specialtyCyclophosphamidemedicine.medical_treatmentChronic lymphocytic leukemiaImmunologyHematopoietic stem cell transplantationTransplantation AutologousBiochemistryGastroenterologyInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansSurvival rateAgedbusiness.industryHazard ratioHematopoietic Stem Cell TransplantationTranslational research Immune Regulation [ONCOL 3]Cell BiologyHematologyMiddle Agedmedicine.diseaseCombined Modality TherapyLeukemia Lymphocytic Chronic B-CellSurgeryFludarabineEuropeSurvival RateTransplantationTreatment OutcomeAlemtuzumabFemalebusinessmedicine.drug
researchProduct

The joint impact of donor and recipient parameters on the outcome of heart transplantation in Germany after graft allocation.

2013

Organ shortage in heart transplantation (HTx) results in increased use of grafts from donors with substantial risk factors. It is discussed controversially which donor characteristics may be detrimental. Therefore, we evaluated the joint impact of donor- and patient-related risk factors in HTx on patient survival by multiple analysis in a nationwide multicentre study after donor selection was carried out. The research database consists of data concerning hearts donated and transplanted in Germany between 2006 and 2008 as provided by Deutsche Stiftung Organtransplantation and the BQS Institute. Multiple Cox regression (significance level 5%, hazard ratio [95% CI]) was conducted (n = 774, rec…

AdultMalemedicine.medical_specialtyDatabases Factualmedicine.medical_treatmentDonor SelectionYoung AdultRisk FactorsInternal medicineGermanymedicineHumansCause of deathProportional Hazards ModelsHeart transplantationHeart FailureTransplantationbiologyProportional hazards modelDonor selectionbusiness.industryHazard ratioGraft SurvivalAge FactorsMiddle Agedmedicine.diseasePulmonary hypertensionTroponinSurvival AnalysisTissue DonorsSurgerymedicine.anatomical_structureTreatment OutcomeMultivariate AnalysisCardiologyVascular resistancebiology.proteinHeart TransplantationFemalebusinessTransplant international : official journal of the European Society for Organ Transplantation
researchProduct

Road Traffic Noise Exposure and Filled Prescriptions for Antihypertensive Medication:A Danish Cohort Study

2020

BACKGROUND: Epidemiological research on effects of transportation noise on incident hypertension is inconsistent. OBJECTIVES: We aimed to investigate whether residential road traffic noise increases the risk for hypertension. METHODS: In a population-based cohort of 57,053 individuals 50-64 years of age at enrollment, we identified 21,241 individuals who fulfilled our case definition of filling formula presented prescriptions and formula presented defined daily doses of antihypertensive drugs (AHTs) within a year, during a mean follow-up time of 14.0 y. Residential addresses from 1987 to 2016 were obtained from national registers, and road traffic noise at the most exposed façade as well as…

AdultMalemedicine.medical_specialtyDenmarkHealth Toxicology and MutagenesisENDOTHELIAL FUNCTIONPopulationBLOOD-PRESSUREENVIRONMENTAL NOISEISCHEMIC-HEART-DISEASE010501 environmental sciences01 natural sciencesTRANSPORTATION NOISECohort Studies03 medical and health sciences0302 clinical medicineAir PollutionEnvironmental healthEpidemiologyHumansMedicine030212 general & internal medicineMedical prescriptioneducationAntihypertensive AgentsProportional Hazards Models0105 earth and related environmental sciencesRISKeducation.field_of_studyINCIDENT HYPERTENSIONbusiness.industryProportional hazards modelMORTALITYResearchPublic Health Environmental and Occupational HealthAIR-POLLUTIONEnvironmental ExposureMiddle AgedLONG-TERM EXPOSUREConfidence intervalNoisePrescriptionsNoise TransportationHypertensionCohortFemalebusinessCohort study
researchProduct

Leisure-time cross-country skiing is associated with lower incidence of type 2 diabetes:A prospective cohort study

2019

Background Cross-country skiing is associated with reduction in risk of adverse vascular outcomes, but its association with type 2 diabetes is uncertain. We aimed to assess the associations between leisure-time cross-country skiing habits and incident type 2 diabetes. Methods We analysed the data of 2483 middle-aged men with no history of diabetes at baseline in the Kuopio Ischemic Heart Disease prospective study. The frequency, average duration, and intensity of leisure cross-country skiing were assessed at baseline using a 12-month physical activity questionnaire. Hazard ratios (HRs) (95% CIs) for type 2 diabetes were estimated. Results During a median follow-up of 21.6 years, 539 men dev…

AdultMalemedicine.medical_specialtyEndocrinology Diabetes and Metabolismphysical activity030209 endocrinology & metabolismType 2 diabetes030204 cardiovascular system & hematologyMetabolic equivalent03 medical and health sciencesLeisure Activities0302 clinical medicineEndocrinologySkiingInternal medicineDiabetes mellitusEpidemiologyInternal MedicineHumansMedicineProspective StudiesProspective cohort studyExerciseFinlandbusiness.industryIncidenceHazard ratioMiddle AgedPrognosismedicine.diseaseDiabetes Mellitus Type 2high-intensity exercise trainingFemaletype 2 diabetesbusinessRisk assessmenthuman activitiescross-country skiingFollow-Up StudiesCohort study
researchProduct

NOA-05 phase 2 trial of procarbazine and lomustine therapy in gliomatosis cerebri.

2011

The NOA-05 multicenter trial was performed to analyze the efficacy of primary chemotherapy with procarbazine and lomustine (PC) in patients with gliomatosis cerebri (GC) and to define clinical, imaging, and molecular factors influencing outcome.Thirty-five patients with previously untreated GC were treated with up to six 56-day courses of 110mg/m(2) lomustine on day 1 and 60mg/m(2) procarbazine on days 8 to 21. The primary endpoint was the rate of patients without therapy failure (defined as progressive disease, death from any cause, or termination of PC therapy before the end of course 4) at 8 months after the beginning of PC chemotherapy.The failure-free survival rate at 8 months was 50.3…

AdultMalemedicine.medical_specialtyEndpoint DeterminationGliomatosis cerebriAntineoplastic AgentsGene mutationProcarbazineGastroenterologyDisease-Free SurvivalLomustineInternal medicineMulticenter trialAntineoplastic Combined Chemotherapy ProtocolsBiomarkers TumorMedicineHumansProspective StudiesKarnofsky Performance StatusSurvival rateDNA Modification MethylasesAgedbusiness.industryTumor Suppressor ProteinsHazard ratioBrainLomustineMiddle Agedmedicine.diseasePrognosisCombined Modality TherapyMagnetic Resonance ImagingNeoplasms NeuroepithelialSurvival AnalysisSurgeryDNA Repair EnzymesTreatment OutcomeNeurologyProcarbazineSample SizeDisease ProgressionFemaleNeurology (clinical)businessProgressive diseasemedicine.drugAnnals of neurology
researchProduct

Clinicopathological characteristics of Epstein-Barr virus-positive gastric cancer in Latvia

2019

Objective Epstein-Barr virus (EBV)-associated gastric cancer has been proposed to be a distinct gastric cancer molecular subtype. The prognostic significance of EBV infection in gastric cancer remains unclear and needs further investigation. Our study aimed to analyze EBV-positive and EBV-negative gastric cancer patients regarding their personal and tumor-related characteristics, and compare their overall survival. Methods Gastric cancer patients consecutively treated at the Riga East University Hospital during 2009-2016 were identified retrospectively. Tumor EBV status was determined by in-situ hybridization for EBV-encoded RNA (EBER). Information about clinicopathological characteristics …

AdultMalemedicine.medical_specialtyEpstein-Barr Virus InfectionsComorbidityKaplan-Meier EstimateAdenocarcinomaGastroenterologyHospital recordsArticle03 medical and health sciencesYoung Adult0302 clinical medicineAge DistributionStomach NeoplasmsInternal medicinehemic and lymphatic diseasesmedicineHumansStage (cooking)Sex DistributionAgedNeoplasm StagingProportional Hazards ModelsRetrospective StudiesAged 80 and overHepatologyStage I Gastric Cancerbusiness.industryHazard ratioSmokingGastroenterologyCancerEpstein-Barr Virus PositiveMiddle AgedOverweightUniversity hospitalmedicine.diseasePrognosisLatviaConfidence intervalSurvival Rate030220 oncology & carcinogenesis030211 gastroenterology & hepatologyFemaleNeoplasm Gradingbusiness
researchProduct

Significance of preoperative C-reactive protein as a parameter of the perioperative course and long-term prognosis in squamous cell carcinoma and ade…

2006

AIM: C-reactive protein (CRP) is an acute-phase reactant and a known indicator of the malignant potential of the tumour. The aim of this study was to investigate the significance of preoperative CRP as a parameter of the perioperative course and long-term prognosis in patients with squamous cell carcinoma and adenocarcinoma of the oesophagus. METHODS: Serum CRP was determined preoperatively in 291 of 371 patients undergoing oesophagectomy for cancer from December 1989 to March 2004. Median patient age was 59 (28-79) year, 82.5% of patients were males. Squamous cell carcinoma was diagnosed in 151 (51.9%) and adenocarcinoma in 122 patients. Transhiatal oesophagectomy was done in 151 (51.9%) p…

AdultMalemedicine.medical_specialtyEsophageal NeoplasmsAdenocarcinomaSeverity of Illness IndexGastroenterologyPerioperative CarePredictive Value of TestsInternal medicineBiomarkers TumorOdds RatiomedicineHumansSurvival rateAgedNeoplasm Stagingbiologybusiness.industryC-reactive proteinHazard ratioGastroenterologyCancerGeneral MedicinePerioperativeOdds ratioMiddle AgedPrognosismedicine.diseaseSurgeryC-Reactive ProteinPredictive value of testsMultivariate AnalysisCarcinoma Squamous CellDisease Progressionbiology.proteinAdenocarcinomaFemalebusinessRapid CommunicationFollow-Up StudiesWorld Journal of Gastroenterology
researchProduct

Perianal Fistula-Associated Carcinoma in Crohn's Disease: A Multicentre Retrospective Case Control Study.

2021

Abstract Background and Aims Carcinoma associated with perianal fistula in Crohn’s disease is a pending threat for patients. This study aimed to improve understanding and facilitate development of diagnostic and therapeutic strategies. Methods A retrospective case-control study was conducted at four German hospitals. The analysis included 40 patients with proven malignancy associated with perianal Crohn’s fistulas and 40 randomly selected controls with fistulizing perianal Crohn’s disease. Differences between groups were analysed and multivariate calculations were performed to describe risk factors for oncological outcomes. Results Histology revealed adenocarcinoma in 33/40 patients and squ…

AdultMalemedicine.medical_specialtyFistulaAdenocarcinomaMalignancyGastroenterology03 medical and health sciencesYoung Adult0302 clinical medicineCrohn DiseaseInternal medicineGermanyCarcinomaMedicineHumansRectal FistulaSurvival rateRetrospective StudiesCrohn's diseasebusiness.industryRectal NeoplasmsHazard ratioGastroenterologyMultimodal therapyGeneral Medicinemedicine.disease030220 oncology & carcinogenesisCase-Control StudiesCarcinoma Squamous CellAdenocarcinoma030211 gastroenterology & hepatologyFemalebusinessJournal of Crohn'scolitis
researchProduct

Failure to renew prescriptions for gastroprotective agents to patients on continuous nonsteroidal anti-inflammatory drugs increases rate of upper gas…

2013

Patients with risk factors for gastrointestinal (GI) disorders who continuously use nonsteroidal anti-inflammatory drugs (NSAIDs) also should take gastroprotective agents (GPAs), such as proton pump inhibitors (PPIs). However, it is not clear how many physicians continue to prescribe GPAs to these patients, and whether stopping the GPA prescription increases GI complications.We performed a retrospective, observational, longitudinal study using a validated electronic database of representative general practitioners in France. We analyzed data for 1856 patients at risk for GI events (65 y, past history of GI ulcer, or receiving antiplatelet agents) who received prescriptions for an NSAID and …

AdultMalemedicine.medical_specialtyGastrointestinal DiseasesLogistic regressionGastrointestinal AgentsInternal medicinemedicineHumansLongitudinal StudiesMedical prescriptionAdverse effectAgedRetrospective StudiesAged 80 and overHepatologybusiness.industryHazard ratioAnti-Inflammatory Agents Non-SteroidalGastroenterologyRetrospective cohort studyOdds ratioMiddle AgedConfidence intervalSurgeryFemaleFranceComplicationbusinessClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
researchProduct